October 2023 in “Dermatology practical & conceptual” In this case report, folliculitis decalvans with frontal fibrosing alopecia was observed in a patient with a dark phototype, highlighting the phenotypic spectrum of folliculitis decalvans and lichen planopilaris.
September 2023 in “Chinese Journal of Integrative Nursing” This article discusses Traditional Chinese Medicine approaches to treating alopecia areata, outlining etiology, treatment stages, and methods, but does not report new clinical results.
August 2023 in “Research Square (Research Square)” In this study, researchers observed that Melan A, a melanocytic marker, was significantly expressed in hair follicles of alopecia areata patients and correlated with immune infiltrates, suggesting melanocytes might contribute to the autoimmune response in this condition.
July 2023 in “Research Square (Research Square)” This study offers evidence suggesting a probable causal role of certain gut microbiota in the development of alopecia areata.
July 2023 in “Chinese Journal of Dermatology” In this review, researchers examined the link between COVID-19 and telogen effluvium, a hair loss condition, noting that increased stress, immune response, medications, and worsening of underlying diseases may contribute to this condition post-infection.
May 2023 in “Journal of Cosmetic and Laser Therapy” This research observed that combination therapy targeting different pathogenetic pathways is more effective than monotherapy in treating female pattern hair loss, offering a more aggressive treatment approach that can include modalities such as minoxidil, spironolactone, and finasteride.
April 2023 in “The Egyptian Journal of Hospital Medicine” This case control study investigated serum IL-17A levels in alopecia areata patients compared to healthy controls to explore its potential role in the disease's pathogenesis.
March 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study found that patients with alopecia areata had significantly lower serum levels of zinc and ferritin compared to healthy controls, which may contribute to the disease's pathogenesis and severity.
March 2023 in “World Journal of Biology Pharmacy and Health Sciences” This study observed that patients with alopecia areata had significantly lower serum levels of zinc and ferritin compared to healthy controls, suggesting these deficiencies may contribute to the disease's severity.
October 2022 in “Research, Society and Development” This review discusses the complex nature of telogen effluvium linked to COVID-19 and highlights the effectiveness of correcting triggers and protein-rich diets in reducing hair loss; it reports no new clinical findings.
October 2022 in “Benha Journal of Applied Sciences” This article discusses the role of Dickkopf-1 as a Wnt antagonist affecting hair follicle signaling but does not report new findings on cicatricial or non-cicatricial alopecia.
October 2021 in “Dermatology Reports” This study found that serum IL-17A levels were significantly higher in patients with alopecia areata compared to healthy controls and correlated with disease severity and activity.
September 2020 in “Benha Journal of Applied Sciences” This study found that patients with alopecia areata had lower serum zinc and biotin levels compared to healthy controls, suggesting these deficiencies may play a role in the condition's pathogenesis.
July 2020 in “Benha Medical Journal” This study found that patients with alopecia areata had higher serum TGF-β1 levels than controls, and these levels were associated with disease severity, suggesting a potential role in its pathogenesis.
January 2020 in “Dermatology Review” Early diagnosis and treatment are crucial for managing alopecia areata, morphea, and psoriasis.
July 2018 in “Benha Journal of Applied Sciences” In this study, researchers found that patients with alopecia areata had significantly higher levels of miR-203 in their skin compared to healthy controls.
September 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” This study using a genetic mouse model found that S. aureus-driven dysbiosis sustains inflammatory skin side effects from EGFR inhibitors, suggesting prophylactic antibiotic treatment may reduce rash severity without fixing barrier defects.
August 2017 in “Journal of The American Academy of Dermatology” This review discusses a dermatopathology textbook by Drs Hall, Cockerell, Chisholm, Jessup, Vandergriff, Motaparthi, and Elston, highlighting its detailed content and visual inclusivity of skin conditions in diverse populations, but reports no new research results.
April 2017 in “The journal of investigative dermatology/Journal of investigative dermatology” This study compiled and functionally annotated 489 genes associated with hair disorders, revealing their involvement in diverse biological pathways, including those linked to cancer and cellular signaling.
September 2016 in “Journal of Engineering and Technological Science” Women with telogen effluvium have an imbalance in thiol-disulphide, suggesting oxidative stress may contribute to hair loss.
January 2015 in “Farmatsevtychnyĭ zhurnal” This research discusses the development of a complex tincture for telogen effluvium using nettle, sage, and chestnut leaves, but provides no new clinical results.
This study found that hair cosmetics have strong bacteriostatic properties, suggesting that current microbial test methods for these products should be revised.
February 2013 in “UNESP Institutional Repository (São Paulo State University)” This review discusses the clinical, epidemiological, and pathophysiological aspects of female pattern hair loss and reports no new experimental findings.
January 2013 in “Touro Scholar (Touro College)” This review concluded that Diphenylcyclopropenone may offer the best treatment results for alopecia areata, although further research into the disease's pathogenesis could improve therapeutic options.
January 2012 in “Detergent & Cosmetics” This review discusses the pathologic mechanisms and possible therapeutic methods for androgenic alopecia, focusing on cytokines' role and potential active ingredients, but reports no new clinical results.
This study found that neurotrophins produced by balding dermal papilla cells inhibited both their proliferation and hair follicle growth in vitro, suggesting a potential role in androgenetic alopecia.
December 2010 in “Elsevier eBooks” This article discusses the clinical manifestations of systemic lupus erythematosus and their potential mechanisms, but reports no new experimental results.
January 2007 in “Electronic archive of the library (Vitebsk State Medical University)” This study suggests that in alopecia areata, an altered distribution of cytokines and growth factors in hair follicles may disrupt normal cell proliferation and induce premature hair growth phases.
January 2001 in “Journal of Shenyang Pharmaceutical University” This review discusses recent advancements in understanding the pathogenesis and treatment of alopecia areata and androgenic alopecia using both traditional Chinese and Western medicine, and it reports no new clinical results.
March 1998 in “Journal of Dermatological Science” Eccrine gland activity may be linked to alopecia areata.